Cargando…
Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development
Glycoconjugate vaccines are a critical component of the medical arsenal against infectious diseases. This established field continues, however, to experience failures in the clinic. The lack of fundamental understanding of factors controlling clinical efficacy of glycoconjugate vaccines is discussed...
Autores principales: | Avci, Fikri, Berti, Francesco, Dull, Peter, Hennessey, John, Pavliak, Viliam, Prasad, A. Krishna, Vann, Willie, Wacker, Michael, Marcq, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763769/ https://www.ncbi.nlm.nih.gov/pubmed/31554723 http://dx.doi.org/10.1128/mSphere.00520-19 |
Ejemplares similares
-
A novel mechanism for glycoconjugate vaccine activation of the adaptive immune system
por: Avci, Fikri Y., et al.
Publicado: (2011) -
Researches on a Disease Yet but Little Known, Which Has Received the Name of Softening of the Brain
Publicado: (1820) -
Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design
por: Duke, Jeremy A., et al.
Publicado: (2021) -
Expanding polysaccharide–protein coupling of glycoconjugate vaccines
por: Berti, Francesco
Publicado: (2022) -
Peripartum cardiomyopathy: a global effort to find the cause and cure for the rare and little understood disease
por: Li, Amy, et al.
Publicado: (2022)